Healthcare provider profile · identity verified

Nicole Allen, DO, FAAFP

Family Practice · SPRUCE PINE, NC · NPI 1932550381

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	232	54
Levothyroxine Sodium	Levothyroxine Sodium	194	51
Lisinopril	Lisinopril	188	48
Losartan Potassium	Losartan Potassium	175	44
Omeprazole	Omeprazole	165	45
Rosuvastatin Calcium	Rosuvastatin Calcium	157	44
Jardiance	Empagliflozin	139	24
Spironolactone	Spironolactone	129	28
Gabapentin	Gabapentin	114	28
Metformin Hcl Er	Metformin Hcl	113	26
Montelukast Sodium	Montelukast Sodium	111	30
Metoprolol Succinate	Metoprolol Succinate	101	24
Pantoprazole Sodium	Pantoprazole Sodium	97	25
Amlodipine Besylate	Amlodipine Besylate	91	28
Albuterol Sulfate Hfa	Albuterol Sulfate	89	32
Fluticasone Propionate	Fluticasone Propionate	85	34
Famotidine	Famotidine	83	22
Duloxetine Hcl	Duloxetine Hcl	82	22
Alendronate Sodium	Alendronate Sodium	80	20
Trazodone Hcl	Trazodone Hcl	78	22
Eliquis	Apixaban	63	11
Ozempic	Semaglutide	63	14
Bupropion Xl	Bupropion Hcl	60	13
Celecoxib	Celecoxib	59	16
Ipratropium Bromide	Ipratropium Bromide	59	22
Mirtazapine	Mirtazapine	59	11
Tamsulosin Hcl	Tamsulosin Hcl	54	16
Prednisone	Prednisone	51	29
Tramadol Hcl	Tramadol Hcl	50	suppressed
Xarelto	Rivaroxaban	49	suppressed
Diclofenac Sodium	Diclofenac Sodium	48	23
Sertraline Hcl	Sertraline Hcl	47	11
Linzess	Linaclotide	45	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	16
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	22
Metformin Hcl	Metformin Hcl	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	11
Bumetanide	Bumetanide	32	suppressed
Furosemide	Furosemide	31	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	26
Ondansetron Odt	Ondansetron	31	21
Potassium Chloride	Potassium Chloride	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Gemtesa	Vibegron	28	suppressed
Atenolol	Atenolol	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Emgality Pen	Galcanezumab-Gnlm	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Baclofen	Baclofen	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Fluconazole	Fluconazole	24	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Lubiprostone	Lubiprostone	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Tradjenta	Linagliptin	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diazepam	Diazepam	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Movantik	Naloxegol Oxalate	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Simvastatin	Simvastatin	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Nystatin	Nystatin	17	13
Pregabalin	Pregabalin	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Estradiol	Estradiol	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Ibuprofen	Ibuprofen	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Naproxen	Naproxen	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Cefdinir	Cefdinir	13	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clonidine	Clonidine	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error